Literature DB >> 9867828

Analysis of the MRP8-MRP14 protein-protein interaction by the two-hybrid system suggests a prominent role of the C-terminal domain of S100 proteins in dimer formation.

C Pröpper1, X Huang, J Roth, C Sorg, W Nacken.   

Abstract

Calcium-binding S100 proteins are thought to play a central role in calcium-mediated signal transduction pathways. They consist of two helix-loop-helix, calcium-binding EF-hand domains. A characteristic feature is their tendency to form homo- and/or heterodimeric complexes. This report presents for the first time a functional "in vivo" approach to the analysis of S100 protein dimerization. Using the two-hybrid system we analyzed the dimerization of MRP8 (S100A8) and MRP14 (S100A9), two S100 proteins expressed in myeloid cells. It is reported that the MRP8-MRP14 heteromer is the clearly preferred complex in both man and mouse. The ability to homodimerize, however, appears to be restricted to the murine MRPs. Interaction analysis of chimeric murine/human MRP14 proteins indicates, that the C-terminal EF-hand domain plays a prominent role in MRP8-MRP14 interaction and determines the specificity of dimerization. Site-directed mutagenesis of four evolutionary conserved hydrophobic amino acids, which have been recently supposed to be essential for S100 protein dimerization, suggests that at least one of these, namely the most N-terminal located residue, is not critical for dimerization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9867828     DOI: 10.1074/jbc.274.1.183

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Expression of calcium-binding proteins MRP8 and MRP14 in inflammatory muscle diseases.

Authors:  Stephan Seeliger; Thomas Vogl; Ingo Hubert Engels; J Michael Schröder; Clemens Sorg; Cord Sunderkötter; Johannes Roth
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

2.  Design of high-affinity S100-target hybrid proteins.

Authors:  Atoosa Rezvanpour; Jeremy M Phillips; Gary S Shaw
Journal:  Protein Sci       Date:  2009-12       Impact factor: 6.725

3.  Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment.

Authors:  A Deguchi; T Tomita; U Ohto; K Takemura; A Kitao; S Akashi-Takamura; K Miyake; Y Maru
Journal:  Oncogene       Date:  2015-07-13       Impact factor: 9.867

Review 4.  Transition Metal Sequestration by the Host-Defense Protein Calprotectin.

Authors:  Emily M Zygiel; Elizabeth M Nolan
Journal:  Annu Rev Biochem       Date:  2018-06-20       Impact factor: 23.643

Review 5.  Calcium-dependent and -independent interactions of the S100 protein family.

Authors:  Liliana Santamaria-Kisiel; Anne C Rintala-Dempsey; Gary S Shaw
Journal:  Biochem J       Date:  2006-06-01       Impact factor: 3.857

Review 6.  Nutritional Immunity: S100 Proteins at the Host-Pathogen Interface.

Authors:  Joseph P Zackular; Walter J Chazin; Eric P Skaar
Journal:  J Biol Chem       Date:  2015-06-08       Impact factor: 5.157

7.  Calprotectin expression in vitro by oral epithelial cells confers resistance to infection by Porphyromonas gingivalis.

Authors:  K Nisapakultorn; K F Ross; M C Herzberg
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

8.  Calcium-induced noncovalently linked tetramers of MRP8 and MRP14 are confirmed by electrospray ionization-mass analysis.

Authors:  K Strupat; H Rogniaux; A Van Dorsselaer; J Roth; T Vogl
Journal:  J Am Soc Mass Spectrom       Date:  2000-09       Impact factor: 3.109

Review 9.  Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome.

Authors:  Jan Däbritz; Jason Musci; Dirk Foell
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

Review 10.  Utility of surrogate markers for the prediction of relapses in inflammatory bowel diseases.

Authors:  Jason Orlando Dimitri Musci; Jack Stephen Cornish; Jan Däbritz
Journal:  J Gastroenterol       Date:  2016-03-14       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.